[go: up one dir, main page]

MXPA03007966A - Inhibidores de transcriptasa reversa sin nucleosido. - Google Patents

Inhibidores de transcriptasa reversa sin nucleosido.

Info

Publication number
MXPA03007966A
MXPA03007966A MXPA03007966A MXPA03007966A MXPA03007966A MX PA03007966 A MXPA03007966 A MX PA03007966A MX PA03007966 A MXPA03007966 A MX PA03007966A MX PA03007966 A MXPA03007966 A MX PA03007966A MX PA03007966 A MXPA03007966 A MX PA03007966A
Authority
MX
Mexico
Prior art keywords
alkyl
cr8ar8b
cycloalkyl
reverse transcriptase
transcriptase inhibitors
Prior art date
Application number
MXPA03007966A
Other languages
English (en)
Inventor
W Ogilvie William
Original Assignee
Boehringer Ingelheim Ca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ca Ltd filed Critical Boehringer Ingelheim Ca Ltd
Publication of MXPA03007966A publication Critical patent/MXPA03007966A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

Un compuesto de la formula I: en donde A es una cadena de enlace de alquilo de (C1-3); B es O o S; R1 es H, alquilo de (C1-6), halo, CF3, u OR1a, en donde R1a es H, o alquilo de (C1-6); R2 es H o Me; R3 es H o Me; R4 es H, alquilo de (C1-4), cicloalquilo de (C3-4) y alquilo de (C1-4) cicloalquilo de (C3-7); W se selecciona de la formula (i), (ii), o (iii), en donde a) es una de Y que es SO2 y la otra Y es NR5, con la condicion de que ambos no sean lo mismo, en donde R5 es H, alquilo de (C1-6), cicloalquilo de (C3-6), el alquilo estando substituido, COR5o, COOR5p o CONR5pR5q, y cada uno de R8 es H, alquilo de (C1-4), cicloalquilo de (C3-6), o alquilo de (C1-4) -cicloalquilo de (C3-6); o b) E es CR8aR8b en donde R8a y R8b es H, o alquilo y J es CH2; o J es CR8aR8b y E es CH2, y la linea de puntos represente un enlace sencillo; O C) es C (O) y J es CR8aR8b o J es C(O) y E es CR8aR8b y la linea de puntos representa un enlace sencillo; o d) E y J son CR8aRBb y la linea de puntos representa un doble enlace. Los compuestos de la formula I tienen actividad contra el VIH TN y las cepas mutantes dobles.
MXPA03007966A 2001-03-22 2002-03-21 Inhibidores de transcriptasa reversa sin nucleosido. MXPA03007966A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27804401P 2001-03-22 2001-03-22
PCT/CA2002/000385 WO2002076982A2 (en) 2001-03-22 2002-03-21 Non-nucleoside reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
MXPA03007966A true MXPA03007966A (es) 2004-05-24

Family

ID=23063458

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03007966A MXPA03007966A (es) 2001-03-22 2002-03-21 Inhibidores de transcriptasa reversa sin nucleosido.

Country Status (11)

Country Link
US (1) US6716836B2 (es)
EP (1) EP1373267B1 (es)
JP (1) JP4148780B2 (es)
AT (1) ATE288434T1 (es)
AU (1) AU2002247573A1 (es)
CA (1) CA2441996C (es)
DE (1) DE60202853T2 (es)
ES (1) ES2236500T3 (es)
MX (1) MXPA03007966A (es)
PT (1) PT1373267E (es)
WO (1) WO2002076982A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6706706B2 (en) * 2002-03-27 2004-03-16 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
US6806265B2 (en) * 2002-05-16 2004-10-19 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
JP2006505532A (ja) * 2002-09-19 2006-02-16 ベーリンガー インゲルハイム (カナダ) リミテッド 非ヌクレオシド逆転写酵素インヒビター
ATE331716T1 (de) * 2002-09-19 2006-07-15 Boehringer Ingelheim Ca Ltd Nicht-nukleosidische inhibitoren der reverse transkriptase
JP2013149779A (ja) * 2012-01-19 2013-08-01 Semiconductor Components Industries Llc 半導体装置
CN110121343B (zh) 2016-09-12 2023-11-03 整体健康 用作gpr120调节剂的双环化合物
EP3509587B1 (en) 2016-09-12 2023-12-06 Valo Health, Inc. Monocyclic compounds useful as gpr120 modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
PL181323B1 (pl) * 1994-02-18 2001-07-31 Boehringer Ingelheim Pharma 2-heteroarylo-5,11-dihydro-6H-dipirydo[3,2-b:2’,3'-e][1,4] diazepinyi ich zastosowanie w zapobieganiu i leczeniu zakazen HIV PL PL PL
US5705499A (en) 1995-10-06 1998-01-06 Boehringer Ingelheim Pharmaceuticals, Inc. 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection
TWI270547B (en) 2000-06-16 2007-01-11 Boehringer Ingelheim Ca Ltd Non-nucleoside reverse transcriptase inhibitors

Also Published As

Publication number Publication date
EP1373267B1 (en) 2005-02-02
WO2002076982A2 (en) 2002-10-03
ATE288434T1 (de) 2005-02-15
US6716836B2 (en) 2004-04-06
WO2002076982A3 (en) 2002-12-12
CA2441996A1 (en) 2002-10-03
JP4148780B2 (ja) 2008-09-10
EP1373267A2 (en) 2004-01-02
PT1373267E (pt) 2005-05-31
US20030069226A1 (en) 2003-04-10
DE60202853D1 (de) 2005-03-10
JP2004523590A (ja) 2004-08-05
ES2236500T3 (es) 2005-07-16
DE60202853T2 (de) 2006-02-09
AU2002247573A1 (en) 2002-10-08
CA2441996C (en) 2011-07-19

Similar Documents

Publication Publication Date Title
RS52632B (en) S-TRIAZOLYL ALFA-MERCAPTOACETANILIDE AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE
ATE403429T1 (de) Spiropyrazol-verbindungen
PL365027A1 (en) Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
NO20034661L (no) Nociceptin-analoger
WO2004011453A3 (en) Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles
NO20054425L (no) Heteroarylkarbamoylbenzenderivater
ATE368655T1 (de) Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
SE0100903D0 (sv) Compounds
TNSN07215A1 (en) Potassium salt of an hiv integrase inhibitor
ATE506354T1 (de) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
NO20053246L (no) Kondensert 1,3-dihydroimidazol-ringforbindelse.
EP1709037B8 (en) Hiv protease inhibiting sulfonamides
MXPA03007966A (es) Inhibidores de transcriptasa reversa sin nucleosido.
ATE368645T1 (de) Aminosäurederivate als hiv-protease-inhibitoren
DK1447400T3 (da) Bicyklisk forbindelse
WO2003097644A3 (en) Non-nucleoside reverse transcriptase inhibitors
YU94202A (sh) Ne-nukleozidni inhibitori reverzne transkriptaze
WO2005058841A3 (en) Hiv protease inhibiting compounds
EA200200807A1 (ru) Аминокислотные соединения и их применение в качестве ингибиторов nep, ace и ece
DK1335913T3 (da) Fremgangsmåde til fremstilling af pantoprazol og intermediære deraf
ID30435A (id) Proses-proses untuk menyiapkan perantara-perantara pestisidal
WO2004021969A3 (en) Non-nucleoside reverse transcriptase inhibitors